Serial #86045285
DEAD

Serial Number

86045285

Owner

VERNALIS (R&D) LIMITED

Attorney

Joan K. Archer

Filing Date

Aug 22, 2013

Add to watchlist:

No watchlists yet
View on USPTO

Serial #86045285 Trademark

Serial Number: 86045285 • Registration: 4729961

Serial #86045285 is a trademark filed by VERNALIS (R&D) LIMITED on August 22, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

VERNALIS (R&D) LIMITED (23 trademarks)

100 BERKSHIRE PLACE, WHARFEDALE ROAD
WINNERSH, WOKINGHAM, BERKSHIRE RG41 5RD , GB

Entity Type: 03

Trademark Details

Filing Date

August 22, 2013

Registration Date

May 5, 2015

Published for Opposition

February 17, 2015

Cancellation Date

November 19, 2021

Goods & Services

Pharmaceutical and veterinary preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; Sanitary preparations for medical purposes; Dietetic food and substances for medical or veterinary use in the nature of pasta, breads, cereals, crackers, meat, fruit, vegetables, confectionery, lipids in the nature of margarine, butter substitute, lard, fish oil, butter, peanut oil, soya bean oil, sunflower oil, sesame oil, coconut oil, olive oil, animal-derived fats and oils, plant-derived oils and dairy products in the nature of cheese, milk, butter, yoghurt, cream, and curds, all adapted for medical use; dietary supplements for humans and animals; chemical reagents for medical or veterinary purposes; chemical medical reagents for therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; medical chemical preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; medicines for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders

Scientific and technological services, namely, pharmaceutical product evaluation, development and testing services; industrial analysis and research services in the nature of pharmaceutical product evaluation, development and testing services; biotechnology research; chemical research; research consulting in the field of pharmaceutical product evaluation, development and testing services; scientific, medical and clinical research and development in the nature of pharmaceutical product evaluation, development and testing services; research and development in the nature of pharmaceutical product evaluation, development and testing services; laboratory research services relating to pharmaceuticals; pharmaceutical research; medical and scientific laboratory services; laboratory testing services in the field of pharmaceutical product evaluation, development and testing services; testing of pharmaceuticals; chemical analysis; technological research in the nature of pharmaceutical product evaluation, development and testing services; conducting product evaluations in the field of new pharmaceuticals; inspection of pharmaceuticals; pharmaceutical product evaluation; pharmaceutical drug development services; information, advisory and consultancy services relating to all the aforesaid services

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 19, 2021 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 5, 2020 REM1
REGISTERED-PRINCIPAL REGISTER
May 5, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 17, 2015 NPUB
PUBLISHED FOR OPPOSITION
Feb 17, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 12, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 12, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 12, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 12, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 12, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 12, 2015 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 8, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jan 8, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jan 8, 2015 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 2, 2015 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 16, 2014 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 4, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 1, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 26, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 26, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 26, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 26, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 8, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 7, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 7, 2014 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 7, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 8, 2014 GNRN
NON-FINAL ACTION E-MAILED
May 8, 2014 GNRT
NON-FINAL ACTION WRITTEN
May 8, 2014 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2014 CRFA
ASSIGNED TO LIE
Apr 25, 2014 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 8, 2014 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 28, 2013 GNRN
NON-FINAL ACTION E-MAILED
Oct 28, 2013 GNRT
NON-FINAL ACTION WRITTEN
Oct 28, 2013 CNRT
ASSIGNED TO EXAMINER
Oct 28, 2013 DOCK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 1, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 1, 2013 REAP
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 31, 2013 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2013 NWOS
NEW APPLICATION ENTERED
Aug 26, 2013 NWAP